Non-Opioid Pain Relief: SiteOne Therapeutics, which is developing non-opioid painkillers, announced that it has raised a $100 ...

The Garden Grove Police Department will conduct a California driver’s license and driving under the influence (DUI) ...

Seal Beach, CA - On Wednesday, December 18, 2024, the Seal Beach Police Department will conduct a driving under the influence ...

See how Checkpoint Therapeutics, Inc.'s FDA-approved Unloxcyt drug for cSCC is set to disrupt the market with innovative ...

They include: Pipeline and key clinical candidates for these companies: Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, ...

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology ... by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

Checkpoint Therapeutics Inc (CKPT) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.28 or -7.63% from the prior close of $3.67. The stock opened at $4 and touched a low ...

Checkpoint Therapeutics (NASDAQ:CKPT – Free Report) had its price objective hoisted by Lake Street Capital from $4.00 to $7.00 in a research note released on Monday morning,Benzinga reports. Lake ...

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) ...